FIG. 1.

Pharmacodynamic profiles of daptomycin, linezolid, quinupristin-dalfopristin, and vancomycin against VRSA (A) and its presumptive methicillin-resistant parent (B). GC, growth control; D, daptomycin; L, linezolid; Q/D, quinupristin-dalfopristin; V, vancomycin.The lower limit of bacterial quantification is 2.0 log₁₀ CFU/g. Plots represent mean values, and error bars represent standard deviations of 27 quantification determinations (nine samples from three model simulations plated in triplicate).